Back

An innovative multi-disciplinary cardiometabolic clinic for patients with atherosclerotic cardiovascular disease leads to improved risk factor optimisation compared to standard care

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Secondary prevention of cardiovascular disease Secondary Prevention ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Holli Evans

Queen Elizabeth Hospital, Gateshead (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
Mediterranean lifestyle for secondary prevention of cardiovascular disease: the MEDLIFE pilot study
Doctor J. Diaz-Gutierrez (Huelva, ES)
Abstract Slides Video
Presentation thumbnail
In-hospital influenza and COVID-19 vaccine availability during acute coronary syndrome boosts vaccination rates and improves outcomes versus out-of-season patients advised post-discharge vaccination
Doctor A. Meseguer Hernandez (Cartagena, ES)
Abstract Slides Video
Presentation thumbnail
Pre-existing cardiovascular disease does not augment the post-acute sequalae of SARS-CoV-2.
Mr J. Smith (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Early predictors of progression of short paroxysmal atrial fibrillation
Associate Professor T. Danilevich (Vinnytsa, UA)
Abstract Slides Video

Access the full session

Session thumbnail
Secondary prevention of cardiovascular disease

The Event

Event poster

ESC Congress 2025

1 September 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Impact of different clinic models on cardiometabolic risk optimisation and cardioprotective therapies in post myocardial infarction patients with type 2 diabetes
thumbnail
Congress Presentation
Novel preventive cardiology clinic associated with reduced risk of recurrent major adverse cardiovascular events for patients with prior acute coronary syndrome
thumbnail
Congress Session
Optimising cardiovascular care through multidisciplinary approaches and pharmacological strategies

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources